K. Wah Group logo

K. Wah Group

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

K. Wah Group is engaged in property development and investment, entertainment and resorts, hospitality, and construction materials.

Investor Profile

K. Wah Group has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does K. Wah Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Loyal Valley Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Apricot Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CCB Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BOCOM International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Shenzhen Capital Group
Asia, Hunan, China, Nanshan
Co-Investments: 1
Sino Biopharmaceutical
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CI
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by K. Wah Group?

Akeso Biopharma

Zhongshan, Anhui, China

Akeso Biopharma is a biopharmaceutical company committed to the discovery, development, and commercialization of therapies.

BiopharmaBiotechnologyHealth Care
Series DNov 4, 2019
Amount Raised: $150,000,000